Dinoprostone Versus Misoprostol for Cervical Ripening before Diagnostic Hysteroscopy in Nulliparous Women: A Randomized Controlled Trial
Journal Title: The Egyptian Journal of Hospital Medicine - Year 2018, Vol 71, Issue 1
Abstract
<strong>Background: </strong>Hysteroscopy has revolutionized the field of Gynecology and the management of many gynecological conditions. It has now become a standard part in the diagnosis of postmenopausal bleeding by the gynecological surgeons. Cost, convenience, accuracy, and patient acceptability of these procedures are clearly superior to those of traditional surgeries. As gynecologists have grown better acquainted with the benefits and techniques of operative hysteroscopy, it has become the method of choice for treatment of intrauterine pathology. Cervical ripening is a complicated process, being mediated by cytokines, growth factors, hormones and other biochemical compounds. Both dinoglandin and Misoprostol can be used for cervical ripening before introduction of hysteroscopy and hence reduce the incidence of complications. <strong>Objects: </strong>This study aims to assess the efficacy of dinoprostone compared to misoprostol in cervical ripening in nulliparous women undergoing diagnostic hysteroscopy. <strong>Methodology:</strong> a randomized controlled clinical trial comparing dinoprostone versus misoprostol for cervical ripening before diagnostic hysteroscopy in nulliparous women, it included 2 groups, 33 patients each. In the first group named (group D) dinoprostone 3 mg was applied vaginally 6 hours before diagnostic hysteroscopic procedure while in the second group named (group M) 400 mcg misoprostol was applied vaginally at the same timing. <strong>Results:</strong> There was no statistically significant difference between the groups that received misoprostol or dinoprostone with regard to age, duration of marriage, medical disorder, history of gynecological operations and type of gynecological operations. However, the use of misoprostol caused slightly less pain compared to dinoprostone but more side effects occurred with the use of misoprostol. <strong>Conclusion: </strong>There was no significant difference between dinoprostone and misoprostol in priming of cervix before diagnostic hysteroscopy in nulliparous women regarding ease of hysteroscope entry, pain or side effects.
Authors and Affiliations
Eman Helal
Keywords
Related Articles
- EP ID EP583816
- DOI -
- Views 96
- Downloads 0
Antral Follicle Count versus Basal Follicle Stimulating Hormone as Predictors of Ovarian Response in Women Undergoing Superovulation with Long Protocol for Assisted Reproduction
Background: the prediction of ovarian response before undertaking the expensive IVF treatment is quite important; it seemed that Patient characteristics, rather than the stimulation protocol are the determinant of the in...
Systematic Review and Evidence Based Guidance on the Surgical Antibiotic Guidelines Adherence
Background: antibiotic administration is an essential element for any surgical operation success, even if a prior infection was not detected. This is due to the fact that antimicrobial agents do not onl...
Fat Embolism Syndrome Due to Fracture Right Femur: A Case Report
Fat embolism syndrome (FES) is usually associated with fractures of long bones and pelvis. Symptoms usually occurs hours to days after injury. We present a case with fat embolism syndrome due to fracture femur. Prompt...
Operational Difficulties in Obese Patients
Background and aim of the work: to give optimal care for obese surgical patients, surgeons and healthcare personnel should be aware about the surgical problems which may be met in obese patient and how to overcome a vari...
Prevalence and Risk Factors of Dyspnea among General Population of Arar City, Kingdom Saudi Arabia
<span>Background: </span><span>Dyspnea is defined as the subjective experience of breathing discomfort. It is increasing by age and it is a common problem affecting up to half of patients admitted to acute, tertiary care...